We are live on !
Find out more
Oliver Luxxe Assets Portfolio holdings
AUM
$638M
Turnover
12.86%
1-Year Est. Return
30.27%
This Fund
S&P 500
This Quarter Est. Return
-1.43%
1 Year Est. Return
+30.27%
3 Year Est. Return
+136.79%
5 Year Est. Return
+207.15%
10 Year Est. Return
+579.03%
AUM
$638M
AUM Growth
-$42.1M
(-6.2%)
Cap. Flow
-$11.5M
Cap. Flow % of AUM
Cap. Flow %
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
18.8%
Holding
210
New
11
Increased
70
Reduced
92
Closed
16
Avg Time Held
Equity + Options
3.2
years
Top 10 Avg Time Held
Equity + Options
1.4
years
Top 20 Avg Time Held
Equity + Options
1.4
years
Avg Time Held Equity only
3.2
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SS&C Technologies
SSNC
|
+$6.9M |
| 2 |
Salesforce
CRM
|
+$6.68M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$3.1M |
| 4 |
Ulta Beauty
ULTA
|
+$2.92M |
| 5 |
Cousins Properties
CUZ
|
+$2.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Element Solutions
ESI
|
+$6.46M |
| 2 |
TD Synnex
SNX
|
+$5.73M |
| 3 |
MKS Inc
MKSI
|
+$4.19M |
| 4 |
TE Connectivity
TEL
|
+$3.64M |
| 5 |
ExxonMobil
XOM
|
+$3.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.52% |
| 2 | Technology | 14.67% |
| 3 | Industrials | 14.21% |
| 4 | Miscellaneous | 12.02% |
| 5 | Healthcare | 11.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Philip Morris
PM
$316B
| $15.7M | 2.46% |
82,400
-752
| -0.9% | -$142K |
2016 Q2
41 quarters
|
|
2
SPDR Gold Trust
GLD
$141B
| $13.5M | 2.11% |
35,366
+1,258
| +4% | +$492K |
2020 Q2
25 quarters
|
|
3
TSMC
TSM
$2.17T
| $12.1M | 1.9% |
26,596
-427
| -2% | -$181K |
2023 Q1
14 quarters
|
|
|
4
Alphabet (Google) Class A
GOOGL
$4.2T
| $11.9M | 1.87% |
34,648
+8,933
| +35% | +$3.1M |
2019 Q3
28 quarters
|
|
5
Citigroup
C
$207B
| $11.8M | 1.85% |
91,100
-1,497
| -2% | -$202K |
2022 Q3
16 quarters
|
|
6
CVS Health
CVS
$118B
| $11.5M | 1.8% |
134,265
-274
| -0.2% | -$26.8K |
2025 Q3
4 quarters
|
|
|
7
Ulta Beauty
ULTA
$25.3B
| $11.5M | 1.8% |
21,038
+5,640
| +37% | +$2.92M |
2025 Q4
3 quarters
|
|
8
Morgan Stanley
MS
$284B
| $11.2M | 1.76% |
59,779
-856
| -1% | -$182K |
2020 Q1
26 quarters
|
|
9
Gilead Sciences
GILD
$194B
| $10.6M | 1.66% |
70,887
+18,035
| +34% | +$2.53M |
2025 Q1
6 quarters
|
|
10
GE Vernova
GEV
$246B
| $10.2M | 1.59% |
10,686
-2,118
| -17% | -$2.1M |
2024 Q2
9 quarters
|
|
11
NXP Semiconductors
NXPI
$58.3B
| $10M | 1.57% |
42,083
+1,184
| +3% | +$289K |
2025 Q3
4 quarters
|
|
12
GE Aerospace
GE
$324B
| $9.8M | 1.54% |
31,376
-3,675
| -10% | -$1.27M |
2023 Q4
11 quarters
|
|
13
Freeport-McMoran
FCX
$99.1B
| $9.6M | 1.5% |
136,690
-1,791
| -1% | -$122K |
2020 Q4
23 quarters
|
|
14
Reliance Steel & Aluminium
RS
$21.3B
| $9.6M | 1.5% |
24,855
-733
| -3% | -$290K |
2018 Q1
34 quarters
|
|
15
Jones Lang LaSalle
JLL
$13.9B
| $8.99M | 1.41% |
29,434
+1,362
| +5% | +$473K |
2024 Q3
8 quarters
|
|
16
Thermo Fisher Scientific
TMO
$254B
| $8.82M | 1.38% |
13,068
+2,749
| +27% | +$1.63M |
2026 Q1
2 quarters
|
|
17
Baker Hughes
BKR
$54.9B
| $8.69M | 1.36% |
158,272
+1,528
| +1% | +$91.1K |
2023 Q1
14 quarters
|
|
18
Entergy
ETR
$49.9B
| $8.55M | 1.34% |
86,133
-315
| -0.4% | -$34K |
2024 Q2
9 quarters
|
|
19
Parker-Hannifin
PH
$121B
| $8.36M | 1.31% |
8,750
-147
| -2% | -$144K |
2026 Q1
2 quarters
|
|
20
Cisco
CSCO
$423B
| $8.32M | 1.3% |
77,342
-436
| -0.6% | -$49.1K |
2025 Q2
5 quarters
|
|
21
Meta Platforms (Facebook)
META
$1.78T
| $8.14M | 1.28% |
11,223
+434
| +4% | +$271K |
2019 Q4
27 quarters
|
|
22
AbbVie
ABBV
$505B
| $8.04M | 1.26% |
30,725
-760
| -2% | -$195K |
2020 Q1
26 quarters
|
|
23
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $7.98M | 1.25% |
10,465
+208
| +2% | +$158K |
2018 Q1
34 quarters
|
|
24
Ralph Lauren
RL
$22.8B
| $7.86M | 1.23% |
22,124
+465
| +2% | +$171K |
2025 Q2
5 quarters
|
|
25
Wells Fargo
WFC
$248B
| $7.56M | 1.19% |
94,482
-5,414
| -5% | -$468K |
2021 Q2
21 quarters
|
|
Similar funds
Oliver Luxxe Assets's Q3 2026 Portfolio in Review
As of Q3 2026, Oliver Luxxe Assets held 210 positions worth $638M, down 6.2% from $680M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Oliver Luxxe Assets's Q3 2026 filing shows 11 new, 70 increased, 92 reduced and 16 closed positions. Its largest new stake was Salesforce: 32,399 shares worth $7.44M. The largest sale was Element Solutions, an estimated $6.46M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Oliver Luxxe Assets's largest Q3 2026 buy was Salesforce: 32,399 shares worth $7.44M.
- Oliver Luxxe Assets added most to SS&C Technologies in Q3 2026, an estimated $6.9M increase.
- Oliver Luxxe Assets's biggest Q3 2026 reduction was MKS Inc, cutting an estimated $4.19M.
- Oliver Luxxe Assets fully exited Element Solutions in Q3 2026, selling an estimated $6.46M.
- Oliver Luxxe Assets's ten largest holdings make up 19% of its $638M portfolio in Q3 2026.
- Oliver Luxxe Assets opened 11 new positions and closed 16 in Q3 2026.
- Oliver Luxxe Assets's portfolio value fell 6.2% quarter-over-quarter to $638M.
Based on Oliver Luxxe Assets's 13F filing for Q3 2026, filed 14 Oct 2026.